Sumiko Hamamoto

488 total citations
11 papers, 383 citations indexed

About

Sumiko Hamamoto is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Sumiko Hamamoto has authored 11 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Genetics. Recurrent topics in Sumiko Hamamoto's work include Pancreatic function and diabetes (8 papers), Diabetes Treatment and Management (6 papers) and Diabetes and associated disorders (4 papers). Sumiko Hamamoto is often cited by papers focused on Pancreatic function and diabetes (8 papers), Diabetes Treatment and Management (6 papers) and Diabetes and associated disorders (4 papers). Sumiko Hamamoto collaborates with scholars based in Japan. Sumiko Hamamoto's co-authors include Kohei Kaku, Masashi Shimoda, Kazuhito Tawaramoto, Mitsuru Hashiramoto, Yukiko Kanda, Michihiro Matsuki, Kenji Kohara, Koji Nakashima, Tomohiko Kimura and Hidenori Hirukawa and has published in prestigious journals such as Diabetologia, American Journal of Physiology-Endocrinology and Metabolism and Molecular and Cellular Endocrinology.

In The Last Decade

Sumiko Hamamoto

11 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumiko Hamamoto Japan	9	245	241	150	59	44	11	383
Gabriele Kaiser Germany	9	182 0.7×	132 0.5×	158 1.1×	51 0.9×	80 1.8×	11	330
Qicheng Ni China	12	266 1.1×	127 0.5×	179 1.2×	144 2.4×	32 0.7×	18	379
Matthew F. Maulis United States	7	232 0.9×	104 0.4×	148 1.0×	144 2.4×	69 1.6×	9	360
Sasha A. S. Kjeldsen Denmark	9	166 0.7×	226 0.9×	131 0.9×	33 0.6×	87 2.0×	19	362
Kazuaki Yoshizato Japan	11	183 0.7×	122 0.5×	222 1.5×	82 1.4×	91 2.1×	14	398
Cristina B. Guzmán United States	10	200 0.8×	345 1.4×	87 0.6×	84 1.4×	30 0.7×	18	434
Takanari Harada Japan	10	221 0.9×	306 1.3×	208 1.4×	65 1.1×	144 3.3×	12	545
Olof Asplund Sweden	10	166 0.7×	194 0.8×	218 1.5×	133 2.3×	70 1.6×	23	456
Emilia Ottosson-Laakso Sweden	8	251 1.0×	154 0.6×	233 1.6×	182 3.1×	64 1.5×	11	492
Irini Rakatzi Germany	8	165 0.7×	106 0.4×	155 1.0×	61 1.0×	81 1.8×	9	352

Countries citing papers authored by Sumiko Hamamoto

Since Specialization

Citations

This map shows the geographic impact of Sumiko Hamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumiko Hamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumiko Hamamoto more than expected).

Fields of papers citing papers by Sumiko Hamamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumiko Hamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumiko Hamamoto. The network helps show where Sumiko Hamamoto may publish in the future.

Co-authorship network of co-authors of Sumiko Hamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Sumiko Hamamoto. A scholar is included among the top collaborators of Sumiko Hamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumiko Hamamoto. Sumiko Hamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hirukawa, Hidenori, Hideaki Kaneto, Masashi Shimoda, et al.. (2015). Combination of DPP-4 inhibitor and PPARγ agonist exerts protective effects on pancreatic β-cells in diabetic db/db mice through the augmentation of IRS-2 expression. Molecular and Cellular Endocrinology. 413. 49–60. 19 indexed citations

Tatsumi, Fuminori, Hideaki Kaneto, Mitsuru Hashiramoto, et al.. (2015). Anti-hypertensive azelnidipine preserves insulin signaling and glucose uptake against oxidative stress in 3T3-L1 adipocytes. Endocrine Journal. 62(8). 741–747. 8 indexed citations

Kanda, Yukiko, Mitsuru Hashiramoto, Masashi Shimoda, et al.. (2014). Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice. The Journal of Nutritional Biochemistry. 26(3). 219–226. 27 indexed citations

Kimura, Tomohiko, Hideaki Kaneto, Masashi Shimoda, et al.. (2014). Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes. Molecular and Cellular Endocrinology. 400. 78–89. 54 indexed citations

Hamamoto, Sumiko, Yukiko Kanda, Masashi Shimoda, et al.. (2012). Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes. Diabetes Obesity and Metabolism. 15(2). 153–163. 55 indexed citations

Shimoda, Masashi, Yukiko Kanda, Sumiko Hamamoto, et al.. (2011). The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes. Diabetologia. 54(5). 1098–1108. 142 indexed citations

Nakashima, Koji, Masashi Shimoda, Sumiko Hamamoto, et al.. (2011). Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival. Molecular and Cellular Endocrinology. 349(2). 281–288. 9 indexed citations

Kanda, Yukiko, Masashi Shimoda, Kazuhito Tawaramoto, et al.. (2009). Molecular Analysis of db Gene-related Pancreatic .BETA. Cell Dysfunction; Evidence for a Compensatory Mechanism Inhibiting Development of Diabetes in the db Gene Heterozygote. Endocrine Journal. 56(8). 997–1008. 10 indexed citations

Kanda, Yukiko, Masashi Shimoda, Sumiko Hamamoto, et al.. (2009). Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist. American Journal of Physiology-Endocrinology and Metabolism. 298(2). E278–E286. 53 indexed citations

10.

Kawasaki, Fumiko, Shinji Kamei, Fuminori Tatsumi, et al.. (2009). Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy. Internal Medicine. 48(17). 1545–1549. 2 indexed citations

11.

Kanda, Yukiko, Masafumi Matsuda, Sumiko Hamamoto, et al.. (2007). Analysis of waist circumference in Japanese subjects with type 2 diabetes mellitus: Lack of propriety to define the current criteria of metabolic syndrome. Diabetes Research and Clinical Practice. 77(3). S220–S223. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact